Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-19

FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (7-eleven)

View source ↗

Summary

FDA approved a generic version of fexofenadine hydrochloride (ANDA 202039) for allergic rhinitis and chronic urticaria, with 7-eleven as the applicant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexofenadine hydrochloride (fexofenadine hydrochloride)

Snippet

ORIG AP for FEXOFENADINE HYDROCHLORIDE (FEXOFENADINE HYDROCHLORIDE)